Water → N-(6-(5-amino-7-(2-furyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-ylmethyl)-2-pyridylmethyl)-N-methyltrifluoroacetamide
反応式
[CH3:1][NH:2][C:3](=[O:8])[C:4]([F:7])([F:6])[F:5].[H-].[Na+].Br[CH2:12][C:13]1[N:18]=[C:17]([CH2:19][N:20]2[C:24]3[N:25]=[C:26]([NH2:34])[N:27]=[C:28]([C:29]4[O:30][CH:31]=[CH:32][CH:33]=4)[C:23]=3[N:22]=[N:21]2)[CH:16]=[CH:15][CH:14]=1.O>CN(C=O)C>[NH2:34][C:26]1[N:27]=[C:28]([C:29]2[O:30][CH:31]=[CH:32][CH:33]=2)[C:23]2[N:22]=[N:21][N:20]([CH2:19][C:17]3[N:18]=[C:13]([CH2:12][N:2]([CH3:1])[C:3](=[O:8])[C:4]([F:7])([F:6])[F:5])[CH:14]=[CH:15][CH:16]=3)[C:24]=2[N:25]=1参加物
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
A solution of N-methyl-2,2,2-trifluoroacetamide (197 mg, 1.55 mmol) in DMF (5 mL) at 0° C. was treated with sodium hydride (60% dispersion in mineral oil; 62 mg, 1.55 mmol), stirred for 15 min, treated with 3-(6-bromomethyl-2-pyridylmethyl)-7-(2-furyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5-amine (120 mg, 0.310 mmol), stirred at 50° C. for 1 h, cooled to room temperature, poured into water (20 mL), extracted with EtOAc (3×10 mL) and the combined organic phase dried (MgSO4) and concentrated in vacuo to give N-(6-(5-amino-7-(2-furyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-ylmethyl)-2-pyridylmethyl)-N-methyltrifluoroacetamide. A solution of this product in MeOH (20 mL) was treated with a solution of sodium (71 mg, 3.10 mmol) in MeOH (10 mL), stirred for 16 h, concentrated in vacuo, treated with EtOAc (20 mL), filtered through Celite and concentrated in vacuo. The resulting solid was suspended in MeOH (2 mL), treated with HCl (4-M in dioxane, 1.0 mL), stirred for 10 min, concentrated in vacuo and triturated with Et2O to give the title compound (80 mg, 58%) as a yellow solid.
後処理
- stirringstirred at 50° C. for 1 h
- extractionextracted with EtOAc (3×10 mL)
- dry with materialthe combined organic phase dried (MgSO4)
- concentrationconcentrated in vacuo
出典と根拠
- ORDレコード
- ord-b633e2df06b74ff29f4ca41a57531eee
- 出典データセット
- uspto-grants-2008_07
- 特許番号
- US07405219B2
反応ノート
読み込み中…